INNOBRAND

Welcome to the Brand page for “INNOBRAND”, which is offered here for In the statement, column 2, after line 8, priority claimed under sec. 44(d) on france application no. 93/470209, filed 6-1-1993, reg. no. 93/470209, dated 6-1-1993, expires 5-3-2003 should be inserted.;protein concentrates derived from human blood useful for the treatment of diseases like haemophilia or coagulation defects;inno-brand;medical laboratory research and analysis, medical services for the treatment of blood diseases, healthcare services, healthcare services relating to blood diseases;.

Its status is currently believed to be active. Its class is unavailable. “INNOBRAND” is believed to be currently owned by “ASSOCIATION POUR L'ESSOR DE LA TRANSFUSION SANGUINE DANS LA REGION DU NORD”.


Owner:
ASSOCIATION POUR L'ESSOR DE LA TRANSFUSION SANGUINE DANS LA REGION DU NORD
Owner Details
Description:
IN THE STATEMENT, COLUMN 2, AFTER LINE 8, PRIORITY CLAIMED UNDER SEC. 44(D) ON FRANCE APPLICATION NO. 93/470209, FILED 6-1-1993, REG. NO. 93/470209, DATED 6-1-1993, EXPIRES 5-3-2003 SHOULD BE INSERTED.;protein concentrates derived from human blood useful for the treatment of diseases like haemophilia or coagulation defects;INNO-BRAND;medical laboratory research and analysis, medical services for the treatment of blood diseases, healthcare services, healthcare services relating to blood diseases;
Categories: STATEMENT